Trial
NCT04549428
Atezolizumab Plus 8 Gy Single-fraction Radiotherapy for Advanced Oligoprogressive NSCLC
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Oncology Institute of Southern Switzerland
Collaborators
Ente Ospedaliero Cantonale, Bellinzona; Istituto Cantonale di Patologia; Clinical Trial Unit Ente Ospedaliero Cantonale
Condition
NSCLC Stage IV
Intervention
Atezolizumab
Why stopped
Terminated for futility, as determined by an interim data analysis.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-18